IRIS
MARZIO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.570
EU - Europa 5.546
AS - Asia 5.463
SA - Sud America 618
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 9
Totale 19.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.459
SG - Singapore 2.009
CN - Cina 1.593
UA - Ucraina 976
IE - Irlanda 781
IT - Italia 745
TR - Turchia 702
SE - Svezia 642
RU - Federazione Russa 601
GB - Regno Unito 588
BR - Brasile 505
VN - Vietnam 458
FR - Francia 454
IN - India 421
DE - Germania 351
FI - Finlandia 209
PL - Polonia 60
CA - Canada 57
HK - Hong Kong 44
MX - Messico 39
BD - Bangladesh 38
AR - Argentina 35
IQ - Iraq 32
EC - Ecuador 29
KR - Corea 27
ZA - Sudafrica 22
ES - Italia 20
ID - Indonesia 19
JP - Giappone 19
BE - Belgio 17
EU - Europa 17
NL - Olanda 15
RO - Romania 15
CO - Colombia 14
PK - Pakistan 13
CZ - Repubblica Ceca 12
PY - Paraguay 12
LT - Lituania 11
MA - Marocco 11
AT - Austria 10
GR - Grecia 10
IL - Israele 10
UZ - Uzbekistan 10
AU - Australia 9
CL - Cile 8
DZ - Algeria 8
KE - Kenya 8
SA - Arabia Saudita 8
JO - Giordania 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
AL - Albania 5
AZ - Azerbaigian 5
IR - Iran 5
PE - Perù 5
PH - Filippine 5
ET - Etiopia 4
PS - Palestinian Territory 4
PT - Portogallo 4
VE - Venezuela 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
JM - Giamaica 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
SC - Seychelles 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MG - Madagascar 1
MN - Mongolia 1
NI - Nicaragua 1
RE - Reunion 1
RS - Serbia 1
Totale 19.287
Salva come PNG Salva come JPEG
Città #
Singapore 1.342
Jacksonville 1.078
Chandler 779
Dublin 768
San Jose 746
Dearborn 458
Southend 422
Ashburn 400
Princeton 386
Dallas 344
Izmir 333
Beijing 327
Nanjing 327
Wilmington 257
Los Angeles 202
Cambridge 181
Ho Chi Minh City 159
Tongling 135
Buffalo 123
Woodbridge 118
New York 114
Santa Clara 114
Ann Arbor 113
The Dalles 110
Nanchang 104
Hanoi 95
Council Bluffs 70
Boardman 65
Houston 65
Moscow 64
Shenyang 62
Hebei 56
Altamura 54
São Paulo 54
Munich 50
Rome 50
Kunming 49
Hefei 48
Tianjin 46
Jiaxing 44
Kraków 36
Redondo Beach 36
Chieti 35
Hong Kong 35
Milan 34
Hangzhou 32
Da Nang 29
Jinan 26
Bologna 25
Norwalk 24
London 23
Grevenbroich 22
Brooklyn 21
Guangzhou 21
Dong Ket 20
Orange 20
Warsaw 20
Boston 19
Changsha 19
Guayaquil 19
Seoul 19
Haiphong 18
Helsinki 18
Tokyo 18
Washington 18
Frankfurt am Main 17
Brussels 16
Denver 16
Orem 16
Rio de Janeiro 16
Stockholm 16
Toronto 16
Düsseldorf 15
Augusta 14
Belo Horizonte 14
Brasília 14
Chennai 14
Johannesburg 14
Montreal 14
Turku 14
Vinh 14
Chicago 13
Seattle 13
Baghdad 12
Changchun 12
Charlotte 12
Lanzhou 12
Hải Dương 11
Pescara 11
Phoenix 11
San Francisco 11
San Mateo 11
Ankara 10
Atlanta 10
Ningbo 10
Cepagatti 9
Curitiba 9
Fuzhou 9
Guadalajara 9
Amsterdam 8
Totale 11.362
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 404
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 204
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 184
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 171
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 169
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 167
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 166
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 166
Antibacterial effect of plant extracts against Helicobacter pylori 165
24-hour pancolonic motility using a portable electronic probe in healthy subjects 159
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 159
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 155
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 150
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 150
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 149
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 147
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 147
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 143
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 141
Trasmissione di Helicobacter pylori in un modello murino 140
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 140
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 139
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 139
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 139
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 139
Cigarette smoke, ferritin, and lipid peroxidation 138
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 137
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 134
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 134
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 132
Heightened free radical activity in angina pectoris 132
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 132
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 131
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 130
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 130
[Physiopathological bases of the medical treatment of portal hypertension]. 129
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 129
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 129
Detection of Helicobacter pylori in saliva and esophagus 128
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 128
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 126
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 126
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 124
Heparin: does it act as an antioxidant in vivo? 124
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 124
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 123
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 123
Detection of Helicobacter pylori in esophagus and saliva in humans 123
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 122
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 121
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 119
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 119
Masse all'ipocondrio dx e carcinoma della colecisti 119
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 118
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 118
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 117
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 117
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 116
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 114
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 114
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 114
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 114
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 113
Glutathione peroxidase, glutathione reductase and glutathione transferase activities in the human artery, vein and heart. 113
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 112
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 112
Esophageal and gastric motility in patients with gastroesophageal reflux disease 111
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 111
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 110
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 110
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 110
Prolonged anal sphincter manometry in normal human subjects 109
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 109
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 107
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 107
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 107
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 107
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 107
Registrazione delle 24 ore della motilità del piloro in soggetti normali 106
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 106
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 106
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 106
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 106
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 106
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 105
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 105
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 104
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 102
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 102
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 101
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 101
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 101
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 100
Influence of physical activity on gastric emptying of liquids in normal human subjects 100
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 100
LA MALDIGESTIONE 99
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 99
Role of nitric oxide on peristaltic motor activity in an in vitro rabbit intestinal preparation 99
Relationship between interdigestive esophageal and gastric motility in humans 99
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 99
Totale 12.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 190 23 77
2021/2022794 28 12 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/20252.642 189 410 308 38 65 67 48 161 335 110 279 632
2025/20265.156 466 278 668 697 468 367 818 437 563 394 0 0
Totale 19.550